Projecting Pharma's Outlook with Deloitte's Laks PernenkilByGrant PlayterSeptember 6th 2000Laks Pernenkil, a partner for Deloitte’s life sciences consulting business, discusses various findings from Deloitte’s research into the biopharma industry.